July 2023 - Page 2 of 17

FridayJul 28, 2023 1:46 pm

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) Preparing to Meet Surging Graphite Demand as World Shifts to Electrification

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2), a strategic minerals company, is actively exploring its Ruby Graphite Project and aims to prove the economics of the historically producing mine and eventually position itself as the premier North American supplier of high-purity natural graphite for advanced technological applications. “RFLXF’s initial drilling program includes 3,500 total meters of drilling cored to an average depth of 130 meters. Targets for the drill program were identified using data gathered for the initial 43-101 technical report dated Jan. 31, 2023, and historical data from original mining operations,” reads a recent article. “Besides powering fuel cells,…

FridayJul 28, 2023 12:45 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW) Announces New Subsidiary, Provides Update on Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has incorporated a new wholly owned subsidiary: Lexaria Nutraceutical Corp., or LEXX Nutra. According to the announcement, LEXX Nutra was established to support Lexaria’s overall strategy of maximizing the potential for its patented DehydraTECH(TM) technology in a variety of markets. The company issued an exclusive perpetual license to LEXX Nutra, giving the new subsidiary rights to utilize, or sublicense the use of, DehydraTECH in an array of ways, including creating consumer packaged goods (“CPG”) and/or intermediate ingredients composed of any molecule except those associated with nicotine or cannabis. LEXX Nutra…

FridayJul 28, 2023 12:34 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Unique NanoAb Pipeline to Target Large, Growing Markets

BiondVax (NASDAQ: BVXV) is an innovative biotechnology company focused on developing, manufacturing and commercializing potential blockbuster immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company is developing a pipeline of unique nanosized antibody (“NanoAb”) therapies addressing diseases underserved by current treatments with large, growing markets, including dermatological conditions such as psoriasis. “BiondVax is initially targeting IL-17 [the human immune system cytokine, which is implicated in several diseases] for the treatment of psoriasis, where the market for therapeutics is expected to reach $44 billion by 2031,” reads a recent article. “The company’s plan for the IL-17 nanobody…

FridayJul 28, 2023 11:02 am

QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc.’s (XESP) Disruptive Solution Drives Engagement, Meaningful Interactions

Electronic Servitor Publication Network (OTCQB: XESP) is a market disruptor focused on connecting companies and target audiences to drive growth. “XESP’s managed service provides B2B clients with cutting-edge data analysis and intelligent technology to help them reach and connect with their target markets and audiences. XESP helps companies – and their products and services – connect by digitally engaging audiences with content and dialog that otherwise and ordinarily could only be done through direct contact by sales personnel. Their service provides around-the-clock company-consumer interactions, instead of just momentary and episodic contact… The company has developed the Digital Engagement Engine(TM), a…

FridayJul 28, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in China with Chinese Patent

Genprex recently received a patent in China covering the use of its drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers The REQORSA-Keytruda drug combination is the subject of Genprex’s ongoing Acclaim-2 clinical trial, which targets patients with advanced, metastatic non-small cell lung cancer whose disease progressed after treatment with Keytruda The company has received patent protection for the REQORSA-Keytruda drug combination in the U.S., Japan, Australia, Russia, Mexico, and China, meaning the company has secured exclusivity in many of the largest markets The granted patents, three Fast Track Designations, and positive preclinical…

FridayJul 28, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Newly Granted Patent for DehydraTECH(TM)–Nicotine by United States Patent and Trademark Office

Lexaria’s new patent includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches The global oral nicotine pouch market was valued at $4.69 billion in 2022 and is expected to grow to $11.91 billion by 2029, driven by the growing ban on e-cigarettes worldwide The white pouch category is one of the fastest-growing, tobacco-free alternatives to smoking and vaping – growing at a CAGR of 13.4% Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that the United…

ThursdayJul 27, 2023 2:03 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Taking Holistic Approach to Reducing Accident Risk with Lidar Technology

Cepton (NASDAQ: CPTN), a lidar innovator, advances high-performance lidar technology currently being applied by leading global companies and governments to vehicles, smart infrastructure and more. “CPTN is dedicated to reducing accident risk through a holistic approach that integrates lidar into traffic systems, intersections, and ADAS-powered vehicles to improve safety for passengers and pedestrians. Through engagements with the world’s leading OEMs, CPTN is taking lidar mainstream by commercializing high-performance, ultra-compact lidar solutions for ADAS that seamlessly integrate into modern vehicle designs. The company is also advancing its Helius(R) Smart Lidar System, which combines its MMT(R) lidar technology with edge computing and…

ThursdayJul 27, 2023 12:37 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract Selected for Poster Presentation at 2023 SNO/ASCO CNS Cancer Conference

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its abstract was selected for in-person poster presentation at the 2023 SNO/ASCO CNS Cancer Conference taking place in San Francisco from Aug. 10-12, 2023. Sandra Silberman, MD, PhD, chief medical officer of CNS Pharmaceuticals, will present the abstract titled, “A randomized, controlled trial of Berubicin, a topoisomerase II poison that appears to cross the blood-brain barrier (‘BBB’), after first-line therapy for glioblastoma multiforme (‘GBM’): Preliminary Results.” Dr. Silberman’s…

ThursdayJul 27, 2023 12:23 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Participation in Upcoming Quantum Computing Webinar, New Research Collaborations

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, will participate in Deloitte’s upcoming quantum computing webinar series. The episode, slated for Aug. 3, 2023, is titled “Quantum Annealing Unleashed: Optimize Your Business Operations” and will feature a discussion by Murray Thom, D-Wave vice president of quantum business innovation; Scott Buchholz, global quantum lead at Deloitte Consulting LLP; and Sal Certo, quantum optimization lead at Deloitte. The 60-minute webinar will begin at noon ET. The hour-long event will include a discussion on annealing quantum computing’s near-term value…

ThursdayJul 27, 2023 12:08 pm

QualityStocksNewsBreaks – GolfLync Inc. Fostering Engagement Around Online Communities with Social Networking App

GolfLync is the company behind the GolfLync app – a social network for matching golf games and players and establishing groups with like-minded interests. “GolfLync designed its product to foster engagement around virtual online golf communities. Whether users aim to build a small team of individuals or larger groups with dozens of members, to golf with neighbors or meet new friends and play on a new course, GolfLync is geared to accommodate such needs. Spouses who enjoy golfing together can easily find other couples to golf with using GolfLync’s search features. Beginners or experienced players can match up with the…

Site Search

Company Search

Month: July 2023